Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG36996

ANKRD27 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The ANKRD27 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in human near-haploid HAP1 cells, targeting the ANKRD27 (VARP) gene. ANKRD27 acts as a guanine nucleotide exchange factor for Rab21, facilitating retromer-dependent integrin recycling, and interacts with VPS29 and SNX27. This model enables studies of endosomal trafficking, cell migration, and integrin-mediated adhesion, and is ideal for haploid genetic screens. Key applications include integrin recycling assays, co-immunoprecipitation of retromer complexes, and Rab21 activation analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    ANKRD27

    Gene Identifier

    NCBI Gene ID 84079

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANKRD27 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the ANKRD27 (VARP) gene in human HAP1 cells. This loss-of-function model enables study of ANKRD27-mediated processes without clonal isolation, minimizing clone-specific biases. The polyclonal format provides heterogeneous edits, ideal for bulk assays and genetic screens where population-level effects are informative.

HAP1 is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype in most cells simplifies gene targeting and phenotype interpretation, making it a workhorse for haploid genetic screens, CRISPR-based functional genomics, and drug?Ctarget interaction studies. The adherent morphology supports imaging assays, and the leukemic origin adds relevance to cancer research.

ANKRD27 (VARP) functions as a guanine nucleotide exchange factor for Rab21, promoting GTP loading and endosome-to-plasma membrane recycling of integrins, particularly ??5??1. It is recruited to endosomal membranes via direct binding to the retromer subunit VPS29 and collaborates with SNX27 to sort integrin cargo away from degradation. Key pathway components include Rab21, VPS29, VPS35, VPS26, SNX27, and integrin cytoplasmic tails. ANKRD27 thus acts downstream of retromer and upstream of integrin surface presentation, regulating adhesion and migration.

In HAP1 cells, ANKRD27 disruption yields a genetically clean model to dissect endocytic recycling without confounding second-allele effects. The knockout polyclonal population is suitable for quantitative assays of integrin trafficking, cell adhesion, and migration. Its haploid background also enhances the efficiency of genetic screens to identify modifiers of ANKRD27-dependent phenotypes, potentially revealing vulnerabilities in leukemia-related endosomal sorting.

Research applications include integrin recycling assays, cell migration and adhesion tests, co-immunoprecipitation of ANKRD27 complexes, and western blotting for Rab21 activation. The polyclonal cells are also well-suited for haploid genetic screens and retromer functional studies. For custom knockout generation or bulk orders, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)